Results 171 to 180 of about 206,382 (334)

Synthetic Lethal Therapy Based on Dimorphism for Systemic Infection of Drug‐Resistant Candida albicans

Advanced Science, EarlyView.
To tackle the alarming mortality rate linked to Candida albicans infections, a synthetic lethal strategy precisely aimed at the two distinct forms of this fungus: yeast and hyphae is formulated. Ultimately, through the innovative use of macrophage membranes for drug delivery, the effectiveness of this strategy is substantially boosted while ...
Yang Gao, Jiahe Su, Jiawei Yuan, Qinyan Cao, Yue Wu, Yuyang Xiao, Guang Yang, Ruomu Xia, Jingpeng Yang, Yanan Li, Lina Wu, He Huang, Lingtong Meng   +12 more
wiley   +1 more source

Long-term use of vitamin K antagonists in patients with atrial fibrillation and cancer incidence: a pharmaco-epidemiological study [PDF]

, 2013
Gentian Denas, Vittorio Pengo, Roberta Joppi, Elisa Cinconze, Luigi Mezzalira, D. Pase, C. Poggiani, Emanuela Rossi, S. Padayattil Jose, Paolo Prandoni   +9 more
openalex   +1 more source

Correction to: Comparative Real-Life Effectiveness and Safety of Dabigatran or Rivaroxaban vs. Vitamin K Antagonists: A High-Dimensional Propensity Score Matched New Users Cohort Study in the French National Healthcare Data System SNDS [PDF]

, 2021
Patrick Blin, Caroline Dureau-Pournin, Jacques Bénichou, Yves Cottin, Patrick Mismetti, Abdelilah Abouelfath, R. Lassalle, C. Droz‐Perroteau, Nicholas Moore   +8 more
openalex   +1 more source

Polystyrene Microplastics Exposure Aggravates Clear Cell Renal Cell Carcinoma Progression via the NF‐κB and TGF‐β Signaling Pathways

Advanced Science, EarlyView.
This research provides the first comprehensive evidence that PS‐MPs exacerbate ccRCC progression by activating the NF‐κB and TGF‐β pathways. These findings establish PS‐MPs as an environmental risk factor for ccRCC progression and identify the NF‐κB and TGF‐β signaling as potential therapeutic targets to mitigate the adverse effects of ‐PS‐MPs exposure.
Shiqi Ye, Jianfeng Xiang, Siqi Zhou, Qintao Ge, Aihetaimujiang Anwaier, Kun Chang, Gang Wei, Jiahe Lu, Xi Tian, Shuxuan Zhu, Yuchen Jiang, Wei Zhang, Tingting Cai, Moran Xu, Dingwei Ye, Danfeng Xu, Tao Wang, Hailiang Zhang, Wenhao Xu   +18 more
wiley   +1 more source

Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy

, 2016
C. Michael Gibson, Duane S. Pinto, Gerald Chi, Douglas Arbetter, Megan K. Yee, Roxana Mehran, Christoph Bode, Jonathan L. Halperin, Freek W.A. Verheugt, Peter Wildgoose, Paul Burton, Martin van Eickels, Serge Korjian, Yazan Daaboul, Purva Jain, Gregory Y.H. Lip, Marc Cohen, Eric D. Peterson, Keith A.A. Fox   +18 more
openalex   +1 more source

Nanozymes Integrated Biochips Toward Smart Detection System

Advanced Science, EarlyView.
This review systematically outlines the integration of nanozymes, biochips, and artificial intelligence (AI) for intelligent biosensing. It details how their convergence enhances signal amplification, enables portable detection, and improves data interpretation.
Dongyu Chen, Wang Zheng, Zhihui Zhang, Shenping Yu, Xinxin Hang, Han Wu, Xiao‐Wei Xiang, Wei Mu, Yanli Jiao, Zaizai Dong, Lingqian Chang   +10 more
wiley   +1 more source

Quality of vitamin K antagonist treatment during the last year of life. [PDF]

Hemasphere
Visser C, Kempers EK, Goedgebuur J, Abbel D, Aldridge SJ, Edwards A, Edwards M, Geersing GJ, Ording AG, van de Leur SJCM, Lifford KJ, Mahé I, Mooijaart SP, Nierman MC, Portielje JEA, Søgaard M, Szmit S, Wiersma NM, Noble SIR, Klok FA, Chen Q, Cannegieter SC, Geijteman ECT, Kruip MJHA, SERENITY Consortium.   +24 more
europepmc   +1 more source

Long-term use of vitamin K antagonists and incidence of cancer: a population-based study [PDF]

, 2010
Vittorio Pengo, Franco Noventa, Gentian Denas, Martino F. Pengo, U Gallo, A.M. Grion, Sabino Iliceto, Paolo Prandoni   +7 more
openalex   +1 more source

Trojan Horse Strategy: How Biomimetic Nanomedicine Remodels the Tumor Microenvironment

Advanced Science, EarlyView.
This review focuses on biomimetic nanomedicines for tumor microenvironment (TME) remodeling, covering their diverse biomimetic types, design principles, and mechanisms of immune cell reprogramming and reversal of immunosuppressive microenvironments, with particular emphasis on their application in synergistic immunotherapy.
Wanrong Wang, Siqi Mu, Juan Zhang, Guisong Shan, Xueqian Li, Ran Wang, Tao Guo, Xiaoyan He   +7 more
wiley   +1 more source

Monitoring and Follow-Up of Patients on Vitamin K Antagonist Oral Anticoagulant Therapy Using Artificial Intelligence: The AIto-Control Project. [PDF]

J Clin Med
Romero-Arana A, Romero-Sibajas N, Arroyo-Bello E, Romero-Ruiz A, Gómez-Salgado J.   +4 more
europepmc   +1 more source